Reference number : 172-2020-2021-Q3-956502, amendment number : , agreement type : C, recipient legal name : BioVectra Inc., recipient country : CA, recipient province : PE, recipient city : Charlottetown|Charlottetown, recipient postal code : C1E 2E6, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : COVID 19 - Feasibility Study to Manufacture a Vaccine, agreement title french : COVID-19 - Étude de faisabilité pour la fabrication d'un vaccin, agreement number : 956502, agreement value : 1874945.0, agreement start date : 2020-09-21, agreement end date : 2021-03-12, description english : Enhanced conceptual engineering design for the installation of vaccine manufacturing capacity at BioVectra's current sites., description french : Amélioration de la conception technique pour l'installation d'une capacité de fabrication de vaccins sur les sites actuels de BioVectra., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada